United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
almus pharmaceuticals ltd - betahistine dihydrochloride - oral tablet - 16mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
phoenix healthcare distribution ltd - betahistine dihydrochloride - oral tablet - 16mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
waymade healthcare plc - betahistine dihydrochloride - oral tablet - 16mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
de pharmaceuticals - betahistine dihydrochloride - oral tablet - 16mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
sigma pharmaceuticals plc - betahistine dihydrochloride - oral tablet - 16mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
betahistine 16mg tablets
mawdsley-brooks & company ltd - betahistine dihydrochloride - oral tablet - 16mg
Australia -
English -
Department of Health (Therapeutic Goods Administration)
betahistine rmb betahistine dihydrochloride 24 mg tablet blister pack
southern xp ip pty ltd - betahistine dihydrochloride, quantity: 24 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
betahistine scp betahistine dihydrochloride 24 mg tablet blister pack
southern xp ip pty ltd - betahistine dihydrochloride, quantity: 24 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/ vomiting); hearing loss (hardness of hearing); tinnitus.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
betahistine actavis betahistine dihydrochloride 8mg tablets blister pack
medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: povidone; stearic acid; lactose monohydrate; crospovidone; microcrystalline cellulose; colloidal anhydrous silica - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus
Australia -
English -
Department of Health (Therapeutic Goods Administration)
betahistine medis betahistine dihydrochloride 8mg tablets blister pack
medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: lactose monohydrate; stearic acid; povidone; crospovidone; microcrystalline cellulose; colloidal anhydrous silica - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus